Search
for
Did you mean Tyrosine Kinase?
Sort by
Research 30 of 1000+
- Repigmentation of leukoderma in a piebald patient associated with a novel c-KIT gene mutation, G592E, of the tyrosine kinase domain
- Clinical Manifestations of Hyperandrogenism and Ovulatory Dysfunction Are Not Associated with His1058 C/T SNP (rs1799817) Polymorphism of Insulin Receptor Gene Tyrosine Kinase Domain in Kashmiri Women with PCOS
- 078 The transmembrane protein LRIG1 regulates receptor tyrosine kinases in skin development and homeostasis
- Epidermal growth factor receptor mutant T790M-L858R-V948R inhibitor from Calophyllum inophyllum L. leaf as potential non-small cell lung cancer drugs
- Trichomegaly of the Eyelashes After Treatment with Erlotinib in Non-small Cell Lung Cancer
- A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- 700 Tyrosine kinase 2 inhibition rescues hair follicles from IL-12–mediated immune privilege collapse and reverses the induction of human alopecia areata in a humanized mouse model
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Characterisation, genomic organisation, expression and function of the mEphA1 receptor Tyrosine Kinase
- Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
- Expression Profiles of Tyrosine Kinases in Cultured Follicular Papilla Cells Versus Dermal Fibroblasts
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- Receptor tyrosine kinase Kit action in skin melanocytes: is it exclusively cell autonomous?
- Bioinformatic analysis of gene expression data reveals Src family protein tyrosine kinases as key players in androgenetic alopecia
- The PDGF/PDGFR pathway as a drug target
- Dasatinib-Induced Leukotrichia in a Patient With Chronic Myelogenous Leukemia
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- MicroRNA control of signal transduction
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Erlotinib-Associated Alopecia in a Lung Cancer Patient
- The Dark Side of Gefitinib: Reflectance Confocal Microscopy Applied to Hair Hyperpigmentation
- Drug-induced hair pigmentation: Clinical perspectives and updates
- Drug-induced scarring and permanent alopecia
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series